Literature DB >> 23695510

IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.

J M Leung1, M Davenport2, M J Wolff3, K E Wiens1, W M Abidi4, M A Poles3, I Cho3, T Ullman4, L Mayer5, P Loke1.   

Abstract

T helper type (Th17) cytokines such as interleukin (IL)-17A and IL-22 are important in maintaining mucosal barrier function and may be important in the pathogenesis of inflammatory bowel diseases (IBDs). Here, we analyzed cells from the colon of IBD patients and show that Crohn's disease (CD) patients had significantly elevated numbers of IL-17+, CD4+ cells compared with healthy controls and ulcerative colitis (UC) patients, but these numbers did not vary based on the inflammatory status of the mucosa. By contrast, UC patients had significantly reduced numbers of IL-22+ cells in actively inflamed tissues compared with both normal tissue and healthy controls. There was a selective increase in mono-IL-17-producing cells from the mucosa of UC patients with active inflammation together with increased expression of transforming growth factor (TGF)-β and c-Maf. Increasing concentrations of TGF-β in lamina propria mononuclear cell cultures significantly depleted Th22 cells, whereas anti-TGF-β antibodies increased IL-22 production. When mucosal microbiota was examined, depletion of Th22 cells in actively inflamed tissue was associated with reduced populations of Clostridiales and increased populations of Proteobacteria. These results suggest that increased TGF-β during active inflammation in UC may lead to the loss of Th22 cells in the human intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695510      PMCID: PMC3870042          DOI: 10.1038/mi.2013.31

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  40 in total

Review 1.  Th17 and regulatory T cells in mediating and restraining inflammation.

Authors:  Dan R Littman; Alexander Y Rudensky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production.

Authors:  Elisabetta Volpe; Maxime Touzot; Nicolas Servant; Marie-Annick Marloie-Provost; Philippe Hupé; Emmanuel Barillot; Vassili Soumelis
Journal:  Blood       Date:  2009-08-24       Impact factor: 22.113

Review 3.  Evolving paradigms in the pathogenesis of IBD.

Authors:  Lloyd Mayer
Journal:  J Gastroenterol       Date:  2009-12-04       Impact factor: 7.527

Review 4.  Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.

Authors:  S Brand
Journal:  Gut       Date:  2009-08       Impact factor: 23.059

Review 5.  Inflammatory bowel disease.

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 6.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

Review 7.  Inflammatory bowel disease.

Authors:  Clara Abraham; Judy H Cho
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

8.  Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

Authors:  Thomas Duhen; Rebekka Geiger; David Jarrossay; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2009-07-05       Impact factor: 25.606

9.  Involvement of the IL-22/REG Ialpha axis in ulcerative colitis.

Authors:  Akira Sekikawa; Hirokazu Fukui; Katsumasa Suzuki; Toyohiko Karibe; Shigehiko Fujii; Kazuhito Ichikawa; Shigeki Tomita; Johji Imura; Keiko Shiratori; Tsutomu Chiba; Takahiro Fujimori
Journal:  Lab Invest       Date:  2010-01-11       Impact factor: 5.662

10.  Galaxy: a web-based genome analysis tool for experimentalists.

Authors:  Daniel Blankenberg; Gregory Von Kuster; Nathaniel Coraor; Guruprasad Ananda; Ross Lazarus; Mary Mangan; Anton Nekrutenko; James Taylor
Journal:  Curr Protoc Mol Biol       Date:  2010-01
View more
  65 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 2.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

Review 3.  Childhood malnutrition: toward an understanding of infections, inflammation, and antimicrobials.

Authors:  Kelsey D Jones; Johnstone Thitiri; Moses Ngari; James A Berkley
Journal:  Food Nutr Bull       Date:  2014-06       Impact factor: 2.069

Review 4.  Mechanisms of interleukin-22's beneficial effects in acute pancreatitis.

Authors:  Chongmin Huan; Daniel Kim; Peiqi Ou; Antonio Alfonso; Albert Stanek
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

5.  Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation.

Authors:  Mei San Tang; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Michael Davenport; Soo Ching Lee; Yvonne Al Lim; Kek Heng Chua; P'ng Loke; Ilseung Cho
Journal:  Gut Microbes       Date:  2015-01-20

6.  Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.

Authors:  Mei San Tang; Rowann Bowcutt; Jacqueline M Leung; Martin J Wolff; Uma M Gundra; David Hudesman; Lisa B Malter; Michael A Poles; Lea Ann Chen; Zhiheng Pei; Antonio G Neto; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Richard A Bonneau; Ilseung Cho; Pʼng Loke
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

Review 7.  Cytokines in inflammatory bowel disease.

Authors:  Markus F Neurath
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

Review 8.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

9.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

10.  Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon.

Authors:  Rowann Bowcutt; Lisa B Malter; Lea Ann Chen; Martin J Wolff; Ian Robertson; Daniel B Rifkin; Michael Poles; Ilseug Cho; P'ng Loke
Journal:  J Immunol Methods       Date:  2015-03-10       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.